KeyBanc maintains Overweight rating on West Pharmaceutical stock Read More: KeyBanc maintains Overweight rating on West Pharmaceutical stock By

Piper Sandler maintains NVIDIA stock Overweight with $150 target Read More: Piper Sandler maintains NVIDIA stock Overweight with $150 target By

BofA raises Snap stock price target to $14.50, maintains Neutral Read More: BofA raises Snap stock price target to $14.50, maintains Neutral By

Berenberg maintains ASML stock Buy rating, EUR800 target Read More: Berenberg maintains ASML stock Buy rating, EUR800 target By Investing.com